Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -276,056 | -368,198 | -523,837 | -444,440 | -440,667 |
| Depreciation Amortization | 84,316 | 13,030 | 14,146 | 14,182 | 1,762 |
| Income taxes - deferred | -140 | 2,708 | -102 | -36 | N/A |
| Accounts receivable | 4,776 | 16,511 | 12,397 | 1,913 | 6,411 |
| Accounts payable and accrued liabilities | -2,884 | 3,103 | -11,690 | 2,382 | 12,967 |
| Other Working Capital | -19,800 | 492 | -22,974 | 16,748 | 21,688 |
| Other Operating Activity | 17,182 | 28,347 | 119,400 | 95,964 | 69,158 |
| Operating Cash Flow | $-192,606 | $-304,007 | $-412,660 | $-313,287 | $-328,681 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 380 | 7,520 | -14,989 | -7,258 | -26,285 |
| Purchase Of Investment | -511,699 | -467,914 | -960,689 | -987,533 | -1,380,865 |
| Sale Of Investment | 650,883 | 826,229 | 1,178,455 | 1,491,004 | 1,614,036 |
| Investing Cash Flow | $139,564 | $365,835 | $202,777 | $496,213 | $206,886 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -250,000 | N/A |
| Common Stock Issued | 30 | 758 | 33,238 | 23,396 | 23,355 |
| Other Financing Activity | 0 | 750 | 3,000 | 146,250 | 0 |
| Financing Cash Flow | $30 | $1,508 | $36,238 | $-80,354 | $23,355 |
| Exchange Rate Effect | 62 | -327 | -92 | 20 | -102 |
| Beginning Cash Position | 88,227 | 25,218 | 198,955 | 96,363 | 194,905 |
| End Cash Position | 35,277 | 88,227 | 25,218 | 198,955 | 96,363 |
| Net Cash Flow | $-52,950 | $63,009 | $-173,737 | $102,592 | $-98,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -192,606 | -304,007 | -412,660 | -313,287 | -328,681 |
| Capital Expenditure | -865 | -5,676 | -14,989 | -7,258 | -26,285 |
| Free Cash Flow | -193,471 | -309,683 | -427,649 | -320,545 | -354,966 |